Patrick G. Lepore, Director at VYNE Therapeutics Inc. (VYNE), bought 20,000 shares at $2.48 ($50K) on 2023-03-20, disclosed to the SEC on 2023-03-22.
Recurring purchase ($50k) by Director following this insider's established cadence. Pattern-driven, low signal.
Something here stands out, but not much.
| Filing → |
| LCI | BUY | 2022-11-14 | $49K | — | Filing → |
| LCI | BUY | 2022-05-17 | $27K | — | Filing → |
| LCI | BUY | 2022-02-10 | $44K | — | Filing → |